التفاصيل البيبلوغرافية
العنوان: |
Evidence-Based Tracking of MDR E. coli from Bovine Endometritis and Its Elimination by Effective Novel Therapeutics. |
المؤلفون: |
Shafique, Laiba, Wu, Siwen, Aqib, Amjad Islam, Ali, Muhammad Muddassir, Ijaz, Misbah, Naseer, Muhammad Aamir, Sarwar, Zaeem, Ahmed, Rais, Saleem, Arslan, Qudratullah, Ahmad, Abdullah Saghir, Pan, Hongping, Liu, Qingyou |
المصدر: |
Antibiotics (2079-6382); Aug2021, Vol. 10 Issue 8, p997, 1p |
مصطلحات موضوعية: |
ENDOMETRITIS, THERAPEUTICS, DRUG resistance in bacteria, BOS, NUCLEOTIDE sequence, ACINETOBACTER baumannii, BACTEROIDES fragilis |
مستخلص: |
Antibiotic-resistant bacteria have become the predominant etiology of endometritis and thus require effective treatment approaches. We used ultrasonography coupled with clinical signs and presented complaints of reproductive issues to investigate the epidemiology, phylogenetic analysis, antimicrobial resistance, and development of novel therapeutics against Escherichia coli isolated from endometritis in bovine (n = 304 from 10 commercial dairy farms). The prevalence of bovine endometritis in this study was 43.75%, while among these, 72.18% samples were positive for E. coli. Nucleotide analysis performed through BLAST and MEGAX showed 98% similarity to the nucleotide sequence of the reference E. coli strain (accession number CP067311.1). The disk diffusion assay revealed pathogen resistance to most antibiotics. Pattern of MIC order of resistance was as follows: enrofloxacin < gentamicin < co-amoxiclav < streptomycin < amoxicillin < metronidazole < oxytetracycline. Field trials revealed the highest recovery rate (in terms of clearance of endometritis and establishment of pregnancy) in case of gentamicin + enrofloxacin (100%) and gentamicin alone (100%), followed by co-amoxiclav + gentamicin (84.61%), oxytetracycline alone (78.57%), and metronidazole + enrofloxacin (33.33%). Hence, the current study reported a higher prevalence of multidrug-resistant E. coli showing considerable similarity with reference strain, and finally, the effective response of novel antibiotics to treat cases. [ABSTRACT FROM AUTHOR] |
|
Copyright of Antibiotics (2079-6382) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |